Cancer screening specialist Exact Sciences (NASDAQ: EXAS) is on fire. The company's shares have soared 69% since 2023 started. Gains of this magnitude can sometimes scare off investors who see limited upside left for the company in question. But in the case of Exact Sciences, there are excellent reasons to be optimistic, particularly for those with a long time horizon of 10 years or more.

Let's consider several reasons why Exact Sciences still looks like an attractive pick.

Continue reading

Source Fool.com